Validated competing event model for the stage I-II endometrial cancer population

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 4, 2014, Pages 888-898

  Carmona, Ruben ^a   Gulaya, Sachin ^a   Murphy, James D ^a   Rose, Brent S ^b   Wu, John ^a   Noticewala, Sonal ^a   McHale, Michael T ^c   Yashar, Catheryn M ^a   Vaida, Florin ^d   Mell, Loren K ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; HEALTH INSURANCE; PATIENT TREATMENT;

CANCER MORTALITY; CLINICAL INFORMATION; CONFIDENCE INTERVAL; CUMULATIVE INCIDENCE; ENDOMETRIAL CANCER; ENDOMETRIOID ADENOCARCINOMA; METHODS AND MATERIALS; NON-CANCER MORTALITY;

DISEASES;

ADULT; ARTICLE; BLACK PERSON; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CHARLSON COMORBIDITY INDEX; COMORBIDITY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOCIAL STATUS;

ADENOCARCINOMA; AGE FACTORS; AGED; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MEDICARE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; REGRESSION ANALYSIS; RISK; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84903120366     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.03.047     Document Type: Article

References (35)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. C.L. Creutzberg, W.L. van Putten, and P.C. Koper et al. Surgery and postoperative radiotherapy versus surgery alone for patient with stage-1 endometrial carcinoma: Multicenter randomized trial. PORTEC study group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
3. ASTEC study group H. Kitchener, and A.M. Swart et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomized study Lancet 373 2009 125 136
4. R.A. Nout, V.T. Smit, and H. Putter et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
5. K.K. Ward, N.R. Shah, and C.C. Saenz et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients Gynecol Oncol 126 2012 176 179
6. J.A. Lachance, C.J. Darus, and L.W. Rice Surgical management and postoperative treatment of endometrial carcinoma Rev Obstet Gynecol 1 2008 97 105
7. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
8. H. Arem, Y. Park, and C. Pelser et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients J Natl Cancer Inst 105 2013 342 349
9. H. Singh, Z. Nugent, and A. Demers et al. Risk of colorectal cancer after diagnosis of endometrial cancer: A population-based study J Clin Oncol 31 2013 2010 2015
10. D. Coon, S. Beriwal, and D.E. Heron et al. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results Int J Radiat Oncol Biol Phys 71 2008 779 783
11. I. Podzielinski, M.E. Randall, and P.J. Breheny et al. Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma Gynecol Oncol 124 2012 36 41
12. L.K. Mell, and J.H. Jeong Pitfalls of using composite primary end points in the presence of competing risks J Clin Oncol 28 2010 4297 4299
13. J.J. Dignam, and M.N. Kocherginsky Choice and interpretation of statistical tests used when competing risks are present J Clin Oncol 26 2008 4027 4034
14. B.S. Rose, J.H. Jeong, and S.K. Nath et al. Population-based study of competing mortality in head and neck cancer J Clin Oncol 29 2011 3503 3509
15. S. Taghipour, D. Banjevic, and J. Fernandes et al. Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study BMC Cancer 12 2012 299
16. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2008). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2011. Available at http://www.seer.cancer. gov. Accessed August 22, 2012.
17. ICD-O-3- SEER site/histology validation list. Rockville, MD: SEER Program Quality Control Section; 2007. Available at http://www.seer.cancer.gov. Accessed August 22, 2012.
18. C.N. Klabunde, A.L. Potosky, and J.M. Legler et al. Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
19. P.C. Austin Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples Stat Med 28 2009 3083 3107
20. E.L. Korn, and F.J. Dorey Applications of crude incidence curves Stat Med 11 1992 813 829
21. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
22. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
23. B. Zhou, J. Fine, and G. Laird Goodness-of-fit test for proportional subdistribution hazards model Stat Med 32 2013 3804 3811
24. L.K. Mell, R. Carmona, and S. Gulaya et al. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: A population based study J Natl Cancer Inst 105 2013 1656 1666
25. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
26. P. Saha, and P.J. Heagerty Time-dependent predictive accuracy in the presence of competing risks Biometrics 66 2010 999 1011
27. D.R. Cox Regression models and life tables J R Stat Soc Series B Stat Methodol B34 1972 187 220
28. L.S. Cook, H.E. Nelson, and M. Cockburn et al. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites Cancer Causes Control 24 2013 61 69
29. S.H. Olson, C.L. Atoria, and M.L. Cote et al. The impact of race and comorbidity on survival in endometrial cancer Cancer Epidemiol Biomarkers Prev 21 2012 753 760
30. P.T. Truong, H.A. Kader, and B. Lacy et al. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer Am J Clin Oncol 28 2005 157 164
31. M.B. Kavanagh, V.E. Von Gruenigen, and K.S. Courneya et al. Effects of a lifestyle intervention on nutrient intake in overweight/obese endometrial cancer survivors e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 4 2009 e143 e147 Available at www.sciencedirect.com Accessed on July 27, 2013
32. K. Zakeri, B.S. Rose, and S. Gulaya et al. Competing event risk stratification may improve the design and efficiency of clinical trials: Secondary analysis of SWOG 8794 Contemp Clin Trials 34 2013 74 79
33. K. Zakeri, B.S. Rose, and L.K. Mell Improving the efficiency of clinical trials through selection models Int J Radiat Oncol Biol Phys 84 Suppl 2013 S45
34. J.L. Lund, L.C. Harlan, and K.R. Yabroff et al. Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease Cancer Invest 28 2010 758 764
35. J.H. Jeong, and J.P. Fine Parametric regression on cumulative incidence function Biostatistics 8 2007 184 196